Kissei Pharmaceutical Co. Ltd.
Kissei Pharmaceutical, a Japanese specialty drug maker, supplies approved therapies for ulcerative colitis, bladder cancer, uterine fibroids, and renal anemia, while its Phase III pipeline (CG0070, Linzagolix, Difelikefalin) fuels expansion in focused therapeutic segments.
Headquarters: Japan (JPN)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Manufacturing
- Industry: Pharmaceutical Manufacturing
- Employees: 1,778
- HQ: Matsumoto
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.